CN Patent

CN114949183B — 一种替尔泊肽粉雾剂及其制备方法

Assigned to Jewim Pharmaceutical Shandong Co ltd · Expires 2023-02-28 · 3y expired

What this patent protects

本发明公开了一种替尔泊肽粉雾剂及其制备方法，属于药物制剂领域。该粉雾剂包括：治疗有效量的替尔泊肽、海藻糖和L‑亮氨酸。本发明通过对大分子吸入粉雾剂处方的开发，不仅增加患者使用的顺应性和便利性，而且提高了药物的生物利用度及用药安全性。

USPTO Abstract

本发明公开了一种替尔泊肽粉雾剂及其制备方法，属于药物制剂领域。该粉雾剂包括：治疗有效量的替尔泊肽、海藻糖和L‑亮氨酸。本发明通过对大分子吸入粉雾剂处方的开发，不仅增加患者使用的顺应性和便利性，而且提高了药物的生物利用度及用药安全性。

Drugs covered by this patent

Patent Metadata

Patent number
CN114949183B
Jurisdiction
CN
Classification
—
Expires
2023-02-28
Drug substance claim
No
Drug product claim
No
Assignee
Jewim Pharmaceutical Shandong Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.